HRI-eIF2a Phosphorylation signaling in oxidative stress and erythropoiesis
HRI-eIF2a Phosphorylation signaling in oxidative stress and erythropoiesis
批准号:
9243242
负责人:
JANE-JANE CHEN
金额:
$33.93万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-07-12 至 2020-03-31
关键词:
AdultAffectAnemiaBFU-EBasophilic ErythroblastBasophilsBone MarrowCD34 geneCellsChronic DiseaseClinicalDevelopmentDiseaseErythroblastsErythrocytesErythroidErythropoiesisEtiologyFetal HemoglobinFetal LiverGene ExpressionGenetic TranslationGlobinHemeHeme IronHemoglobinHemoglobinopathiesHumanIncidenceInfantIronIron deficiency anemiaKnock-inLaboratoriesLeadMalignant NeoplasmsMapsMediatingMediator of activation proteinMendelian disorderMessenger RNAMethodsMolecularMolecular ProfilingMusOutcomeOutcome StudyOxidative StressPathway interactionsPatientsPhenotypePhosphorylationPhosphotransferasesProcessProductionPronormoblastsProteinsRegulationResearchRibosomesRoleSeveritiesSignal TransductionSorting - Cell MovementSpleenStressTechnologyTestingThalassemiaTimeTranscriptional RegulationTranslatingTranslational RegulationTranslationsbiological adaptation to stressdensityembryonic stem cellerythroid differentiationgenome-widegenome-wide analysisin vivoiron deficiencymouse modelnovelnovel therapeuticsprogenitorpublic health relevanceribosome profiling
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Our long-term objective for this proposed research is to contribute to the more comprehensive understanding of the regulation of hemoglobin synthesis and erythropoiesis under stress conditions and in red cell disorders. In this proposal, we focus on translational control by the heme-regulated eIF2� kinase (HRI) in oxidative stress and stress erythropoiesis. Our laboratory has demonstrated that HRI is necessary to reduce ineffective erythropoiesis and to maintain proper gene expression in erythroid precursors during iron deficiency. HRI is also essential for reducing the phenotypic severities of �-thalassemia. Phosphorylation of eIF2� by HRI not only inhibits translation globally, but also selectively increases the translation of ATF4 mRNA in primary erythroid precursors. This HRI-activated ATF4 stress response pathway is necessary to mitigate oxidative stress and to promote erythroid differentiation. Most recently, HRI-eIF2�P pathway has been shown to induce fetal hemoglobin (HbF) production in human CD34+ cells undergoing erythroid differentiation. While transcriptional regulation during erythropoiesis has been studied extensively, much less is known about the role of translational control in this process. We hypothesize that eIF2 �P-mediated translation is necessary to mitigate oxidative stress and to promote erythroid differentiation during stress erythropoiesis. We will employ a recently developed genome-wide approach, ribosome profiling, to study translational regulation during normal and stress erythropoiesis in heme deficiency and in �-thalassemia. A novel line of erythroid-specific eIF2�Ser51Ala knockin (erythroid- �A/A) mice, which are defective in eIF2�P signaling specifically in the erythroid lineage, will be generated. Erythroblasts isolated by FACS sorting from fetal livers of wild type (Wt), Hri-/- and erythroid-A/A mice under iron sufficient and deficint conditions, will be used to study the role of heme, HRI and eIF2�P in regulating in vivo translation genome-wide. In addition, ribosome profiling will also be performed in splenic basophilic erythroblasts of �-thalassemic mice. The outcomes of these proposed studies will elucidate the essential role of heme and eIF2�P-mediated translation in erythropoiesis under stress conditions. This proposed research will also uncover novel molecular mechanisms in translational regulation and new proteins produced in the erythroid lineage during differentiation.
The novel information obtained from these studies will advance the field of erythropoiesis greatly and will have a very significant impact on the development of new therapies for hemoglobinopathies.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Stress-enhanced translation of γ-globin mRNA.
γ-珠蛋白 mRNA 的应激增强翻译。
DOI:
10.1182/blood-2014-09-599290
发表时间:
2014
期刊:
Blood
影响因子:
20.3
作者:
[Chen,Jane-Jane]
通讯作者:
Chen,Jane-Jane
Translational control by heme-regulated elF2α kinase during erythropoiesis.
红血管调节的ELF2α激酶在红细胞生成过程中受到翻译控制。
DOI:
10.1097/moh.0000000000000704
发表时间:
2022-05-01
期刊:
CURRENT OPINION IN HEMATOLOGY
影响因子:
3.2
作者:
[Chen, Jane-Jane, Zhang, Shuping]
通讯作者:
Zhang, Shuping
DOI:
10.1016/j.exphem.2021.10.005
发表时间:
2022-01
期刊:
Experimental hematology
影响因子:
2.6
作者:
[Sjögren SE, Chen J, Mattebo A, Alattar AG, Karlsson H, Siva K, Soneji S, Tedgård U, Chen JJ, Gram M, Flygare J]
通讯作者:
Flygare J
Stressing HbF synthesis: role of translation?
强调 HbF 合成:翻译的作用?
DOI:
10.1182/blood-2013-06-506139
发表时间:
2013
期刊:
Blood
影响因子:
20.3
作者:
[Chen,Jane-Jane, Perrine,Susan]
通讯作者:
Perrine,Susan
DOI:
10.1111/bjh.16202
发表时间:
2020-02
期刊:
BRITISH JOURNAL OF HAEMATOLOGY
影响因子:
6.5
作者:
[Zhang, Shuping, Chen, Jane-Jane]
通讯作者:
Chen, Jane-Jane
共 6 条
HRI-eIF2a Phosphorylation Signaling in Oxidative Stress and Erythropoiesis
-
批准号:8279410
-
项目类别:
-
资助金额:$24.95万
-
财政年份:2010
-
负责人:JANE-JANE CHEN
-
依托单位:
HRI-eIF2a Phosphorylation signaling in oxidative stress and erythropoiesis
-
批准号:8703304
-
项目类别:
-
资助金额:$33.93万
-
财政年份:2010
-
负责人:JANE-JANE CHEN
-
依托单位:
HRI-eIF2a Phosphorylation Signaling in Oxidative Stress and Erythropoiesis
-
批准号:7863731
-
项目类别:
-
资助金额:$25.2万
-
财政年份:2010
-
负责人:JANE-JANE CHEN
-
依托单位:
HRI-eIF2a Phosphorylation signaling in oxidative stress and erythropoiesis
-
批准号:8729681
-
项目类别:
-
资助金额:$7.8万
-
财政年份:2010
-
负责人:JANE-JANE CHEN
-
依托单位:
HRI-eIF2a Phosphorylation signaling in oxidative stress and erythropoiesis
-
批准号:8829233
-
项目类别:
-
资助金额:$33.93万
-
财政年份:2010
-
负责人:JANE-JANE CHEN
-
依托单位:
HRI-eIF2a Phosphorylation Signaling in Oxidative Stress and Erythropoiesis
-
批准号:8110587
-
项目类别:
-
资助金额:$24.95万
-
财政年份:2010
-
负责人:JANE-JANE CHEN
-
依托单位:
HRI/elF2aP Signaling Pathway as Potential Pharmaceutical Targets for Thalassemia
-
批准号:8099953
-
项目类别:
-
资助金额:$0.97万
-
财政年份:2010
-
负责人:JANE-JANE CHEN
-
依托单位:
HRI/elF2aP Signaling Pathway as Potential Pharmaceutical Targets for Thalassemia
-
批准号:7903778
-
项目类别:
-
资助金额:$8.91万
-
财政年份:2009
-
负责人:JANE-JANE CHEN
-
依托单位:
HRI/elF2aP Signaling Pathway as Potential Pharmaceutical Targets for Thalassemia
-
批准号:7674587
-
项目类别:
-
资助金额:$21.0万
-
财政年份:2008
-
负责人:JANE-JANE CHEN
-
依托单位:
HRI/elF2aP Signaling Pathway as Potential Pharmaceutical Targets for Thalassemia
-
批准号:7470479
-
项目类别:
-
资助金额:$25.2万
-
财政年份:2008
-
负责人:JANE-JANE CHEN
-
依托单位:
STRUCTURE/FUNCTION OF HEME REGULATED ELF-2ALPHA KINASE
-
批准号:6350684
-
项目类别:
-
资助金额:$21.56万
-
财政年份:1998
-
负责人:JANE-JANE CHEN
-
依托单位:
STRUCTURE/FUNCTION OF HEME REGULATED ELF-2ALPHA KINASE
-
批准号:2446303
-
项目类别:
-
资助金额:$20.66万
-
财政年份:1998
-
负责人:JANE-JANE CHEN
-
依托单位:
STRUCTURE/FUNCTION OF HEME REGULATED ELF-2ALPHA KINASE
-
批准号:6150559
-
项目类别:
-
资助金额:$20.93万
-
财政年份:1998
-
负责人:JANE-JANE CHEN
-
依托单位:
STRUCTURE/FUNCTION OF HEME REGULATED ELF-2ALPHA KINASE
-
批准号:2872246
-
项目类别:
-
资助金额:$20.68万
-
财政年份:1998
-
负责人:JANE-JANE CHEN
-
依托单位:
Regulation of Protein Synthesis and Erythropoiesis
-
批准号:7168818
-
项目类别:
-
资助金额:$36.88万
-
财政年份:1979
-
负责人:JANE-JANE CHEN
-
依托单位:
REGULATION OF PROTEIN SYNTHESIS AND ERYTHROPOIESIS
-
批准号:2136998
-
项目类别:
-
资助金额:$29.9万
-
财政年份:1979
-
负责人:JANE-JANE CHEN
-
依托单位:
REGULATION OF PROTEIN SYNTHESIS AND ERYTHROPOIESIS
-
批准号:2900122
-
项目类别:
-
资助金额:$29.49万
-
财政年份:1979
-
负责人:JANE-JANE CHEN
-
依托单位:
REGULATION OF PROTEIN SYNTHESIS AND ERYTHROPOIESIS
-
批准号:6176508
-
项目类别:
-
资助金额:$30.38万
-
财政年份:1979
-
负责人:JANE-JANE CHEN
-
依托单位:
Regulation of Protein Synthesis and Erythropoiesis
-
批准号:6688995
-
项目类别:
-
资助金额:$38.89万
-
财政年份:1979
-
负责人:JANE-JANE CHEN
-
依托单位:
Regulation of Protein Synthesis and Erythropoiesis
-
批准号:6829082
-
项目类别:
-
资助金额:$38.89万
-
财政年份:1979
-
负责人:JANE-JANE CHEN
-
依托单位:
海外基金